Hannah T. Ryles

783 total citations
7 papers, 520 citations indexed

About

Hannah T. Ryles is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Hannah T. Ryles has authored 7 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Cancer Research. Recurrent topics in Hannah T. Ryles's work include Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hannah T. Ryles is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Hannah T. Ryles collaborates with scholars based in United States, Switzerland and New Zealand. Hannah T. Ryles's co-authors include Kateryna Krytska, Yaël P. Mossé, Jin H. Park, Mark A. Lemmon, Nicole R. Infarinato, Renata Sano, Andrew Wood, Eric Rappaport, Daniel A. Weiser and Ravi Radhakrishnan and has published in prestigious journals such as Cancer Cell, Clinical Cancer Research and Obstetrics and Gynecology.

In The Last Decade

Hannah T. Ryles

7 papers receiving 516 citations

Peers

Countries citing papers authored by Hannah T. Ryles

Since Specialization

Citations

This map shows the geographic impact of Hannah T. Ryles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah T. Ryles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah T. Ryles more than expected).

Fields of papers citing papers by Hannah T. Ryles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah T. Ryles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah T. Ryles. The network helps show where Hannah T. Ryles may publish in the future.

Co-authorship network of co-authors of Hannah T. Ryles

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah T. Ryles. A scholar is included among the top collaborators of Hannah T. Ryles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah T. Ryles. Hannah T. Ryles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Changing Practices in the Surgical Management of Adnexal Torsion 2023 ·Obstetrics and Gynecology ·Hannah T. Ryles, (unknown), Uduak U. Andy, (unknown)	3
2	Changing Practices in the Surgical Management of Adnexal Torsion: An Analysis of the National Surgical Quality Improvement Program Database 2023 ·Obstetrical & Gynecological Survey ·Hannah T. Ryles, (unknown), Uduak U. Andy, (unknown)	1
3	Is Nocturia Associated With Detrusor Underactivity? 2021 ·Female Pelvic Medicine & Reconstructive Surgery ·Hannah T. Ryles, (unknown), Pamela J. Levin, Uduak U. Andy, Heidi S. Harvie, Lily A. Arya	5
4	Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma 2016 ·Clinical Cancer Research ·Andrew Wood, Kateryna Krytska, Hannah T. Ryles, Nicole R. Infarinato, Renata Sano, (unknown), Lori S. Hart, Frederick J. King, Timothy R. Smith, Edward Ainscow, Kathryn B. Grandinetti, Tove Tuntland, Sunkyu Kim, Giordano Caponigro, You He, Shiva Krupa, Nanxin Li, Jennifer L. Harris, Yaël P. Mossé	67
5	The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma 2015 ·Cancer Discovery ·Nicole R. Infarinato, Jin H. Park, Kateryna Krytska, Hannah T. Ryles, Renata Sano, (unknown), Yimei Li, Helen Y. Zou, Nathan V. Lee, Tod Smeal, Mark A. Lemmon, Yaël P. Mossé	116
6	Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma 2015 ·Clinical Cancer Research ·Kateryna Krytska, Hannah T. Ryles, Renata Sano, Pichai Raman, Nicole R. Infarinato, (unknown), Monish Ram Makena, Michael M. Song, C. Patrick Reynolds, Yaël P. Mossé	76
7	ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma 2014 ·Cancer Cell ·Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe, Jin H. Park, Kateryna Krytska, Hannah T. Ryles, Marci Laudenslager, Eric Rappaport, Andrew Wood, Patrick McGrady, Michael D. Hogarty, Wendy B. London, Ravi Radhakrishnan, Mark A. Lemmon, Yaël P. Mossé	252

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact